FDA approves Sciele's new Sular formulation

01/2/2008 | Forbes

The FDA has approved all four dosage strengths of Sciele Pharma's new formulation for its Sular hypertension drug, the company announced Wednesday. Sciele intends to launch its new Sular formulation, which uses SkyePharma's Geomatrix technology, within the first quarter.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA